Financial Performance - The company's operating revenue for the first half of 2021 was approximately CNY 1,037.61 million, representing a year-on-year increase of 7.47% compared to CNY 965.51 million in the same period last year[17]. - The net profit attributable to shareholders of the listed company decreased by 38.18% to CNY 59.26 million, down from CNY 95.86 million in the previous year[17]. - Basic earnings per share decreased by 37.21% to CNY 0.27, down from CNY 0.43 in the same period last year[18]. - The gross profit margin decreased to 20.14%, down 11.39 percentage points from the previous year[33]. - The company reported a comprehensive income of CNY 59,261,649.65 for the first half of 2021[121]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -55.36 million, a significant decline of 219.76% compared to CNY 46.23 million in the same period last year[17]. - Cash flow from operating activities showed a net outflow of CNY 55,362,649.08, compared to a net inflow of CNY 46,228,827.78 in the first half of 2020[113]. - The company's cash and cash equivalents decreased to CNY 312,622,576.84 from CNY 505,708,846.56, a decline of approximately 38.19%[98]. - The company's cash and cash equivalents at the end of the period were CNY 56,763,896.78, down from CNY 82,787,763.32 at the end of the previous year[118]. Assets and Liabilities - The total assets of the company increased by 3.48% to CNY 2,416.16 million, compared to CNY 2,335.00 million at the end of the previous year[17]. - Total liabilities increased to CNY 702,711,889.19 from CNY 631,220,231.84, which is an increase of approximately 11.32%[100]. - The company's equity attributable to shareholders was CNY 1,713,448,380.31, slightly up from CNY 1,703,781,974.56, showing a marginal increase of about 0.43%[100]. Research and Development - The company has established a complete R&D, procurement, production, quality inspection, marketing, and sales system to ensure stable and healthy development[23]. - The company has developed a patented compound, Quikazone, which is the first new pesticide approved for use in sorghum fields, addressing a significant market gap[29]. - Research and development expenses for the first half of 2021 were ¥48,831,986.77, compared to ¥50,862,648.69 in the same period of 2020[106]. Environmental Compliance - The company’s wastewater discharge total was 4.76 tons with a concentration of 168 mg/L, which is within the permitted limits[56]. - The company has maintained effective pollution control measures, ensuring no environmental pollution incidents occurred during the reporting period[55]. - The company reported no significant administrative penalties related to environmental issues during the reporting period[70]. Shareholder Information - The company distributed cash dividends of CNY 55.47 million (including tax) to shareholders, with a payout of CNY 3.50 per 10 shares[85]. - The largest shareholder, Wang Xianquan, increased his holdings by 21,020,837 shares, bringing his total to 73,572,928 shares, representing 33.16% of the total shares[90]. - The total number of ordinary shareholders reached 10,366 by the end of the reporting period[88]. Market Position and Industry Outlook - The company is a leader in the selective herbicide segment, emphasizing technological research and development, quality, scale, and brand strength[29]. - The company anticipates challenges in the pesticide industry due to intensified competition and increased regulatory scrutiny[27]. - The agricultural sector is expected to benefit from increased investment in high-quality production materials due to rising farmer incomes and supportive government policies[28]. Corporate Governance - The company has made changes in its board and management personnel, including the election of a new general manager and independent directors[51]. - The company has not reported any significant environmental information updates or changes during the reporting period[70]. - The financial statements were approved by the board of directors on August 27, 2021, ensuring compliance with regulatory requirements[134].
先达股份(603086) - 2021 Q2 - 季度财报